Literature DB >> 10338242

Electrocardiographic manifestations: benign early repolarization.

W J Brady1, T C Chan.   

Abstract

Early repolarization, also known as benign early repolarization (BER) or normal variant, is noted in approximately 1% of the population and in up to 48% of patients seen in the Emergency Department with chest pain. BER represents a benign variant of the normal electrocardiogram and is one of several syndromes producing electrocardiographic ST segment elevation (STE). The electrocardiogram (EKG) findings of BER include diffuse or widespread ST segment elevation, upward concavity of the initial portion of the ST segment, notching or slurring of the terminal QRS complex, and concordant T waves of large amplitude. This article focuses on BER and includes the electrocardiographic findings useful in making the diagnosis as well as distinguishing BER from other STE syndromes.

Entities:  

Mesh:

Year:  1999        PMID: 10338242     DOI: 10.1016/s0736-4679(99)00010-4

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  4 in total

Review 1.  How Dangerous Is Hyperkalemia?

Authors:  John R Montford; Stuart Linas
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

2.  The prevalence of abnormal ECG in trained sportsmen.

Authors:  V K Malhotra; Navreet Singh; R S Bishnoi; D S Chadha; P Bhardwaj; H Madan; R Dutta; A K Ghosh; S Sengupta; P Perumal
Journal:  Med J Armed Forces India       Date:  2015-08-31

3.  ST elevation and inverted T wave as another normal variant mimicking acute myocardial infarction: the prevalence, age, gender, and racial distribution.

Authors:  Henri Roukoz; Kyuhyun Wang
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-01       Impact factor: 1.468

Review 4.  12-lead electrocardiogram features of arrhythmic risk: A focus on early repolarization.

Authors:  Caterina Rizzo; Francesco Monitillo; Massimo Iacoviello
Journal:  World J Cardiol       Date:  2016-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.